Sugi Predict

Sugi Predict / Compounds / SCHEMBL15028249

SCHEMBL15028249

SCHEMBL15028249

CCOC(=O)CCCCCCCC(C(=O)OCC)C(=O)C(CCCCCCCC(=O)OCC)C(=O)OCC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.51
▸ CYP1A2 P05177 1/20 0.48
▸ TDP1 Q9NUW8 4/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ CYP3A4 P08684 2/20 0.45
▸ TSHR P16473 2/20 0.45
▸ ALOX15 P16050 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ DGKA P23743 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ GAA P10253 1/20 0.43
▸ MAPT P10636 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ PAM P19021 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ DUSP3 P51452 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25212852 1.00 KMT2A (0.51) KMT2ACYP1A2TDP1ALDH1A1CYP3A4
SCHEMBL24715407 0.98 KMT2A (0.50) KMT2ACYP1A2TDP1ALDH1A1CYP3A4
SCHEMBL7971092 0.93 KMT2A (0.54) KMT2ACYP1A2TDP1ALDH1A1CYP3A4
SCHEMBL11598732 0.93 KMT2A (0.54) KMT2ACYP1A2TDP1ALDH1A1CYP3A4
SCHEMBL16376193 0.89 KMT2A (0.46) KMT2ACYP1A2TDP1ALDH1A1CYP3A4
SCHEMBL25616359 0.88 CYP1A2 (0.47) KMT2ACYP1A2TDP1ALDH1A1CYP3A4
SCHEMBL11614940 0.88 KMT2A (0.50) KMT2ACYP1A2TDP1ALDH1A1CYP3A4
SCHEMBL4800391 0.88 KMT2A (0.50) KMT2ACYP1A2TDP1ALDH1A1CYP3A4
SCHEMBL11654967 0.86 KMT2A (0.49) KMT2ACYP1A2TDP1ALDH1A1CYP3A4
SCHEMBL4835509 0.85 CYP1A2 (0.52) KMT2ACYP1A2TDP1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260102348-A1 COMPOUND OR SALT THEREOF AND LIPID PARTICLES FUJIFILM CORPORATION (JP) 2026-04-16 — — US disclosed
US-12508226-B2 Lipid composition FUJIFILM CORPORATION (JP) 2025-12-30 — — US disclosed
US-12370143-B2 Compound or salt thereof and lipid particles FUJIFILM CORPORATION (JP) 2025-07-29 — — US disclosed
EP-4328309-B1 LIPID COMPOSITION FUJIFILM CORP (JP) 2025-07-02 — — EP disclosed
WO-2025104695-A1 IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES THEREOF Corti Therapeutics Pte. Ltd. (SG) 2025-05-22 — — WO disclosed
US-12285525-B2 Compound or salt thereof and lipid particles FUJIFILM CORPORATION (JP) 2025-04-29 — — US disclosed
US-20250114305-A1 LIPIDIC COMPOUNDS, AND USES THEREOF SANOFI (FR) 2025-04-10 — — US disclosed
CN-116172975-B Lipid particle, nucleic acid drug comprising same, and composition for nucleic acid delivery 富士胶片株式会社 2025-03-28 — — CN disclosed
EP-4466248-A1 LIPIDIC COMPOUNDS, AND USES THEREOF Sanofi (FR) 2024-11-27 — — EP disclosed
CN-114728016-B Lipid composition 富士胶片株式会社 2024-10-29 — — CN disclosed
CN-113924128-A Lipid composition 富士胶片株式会社 2022-01-11 — — CN disclosed
WO-2021095876-A1 LIPID COMPOSITION 富士フイルム株式会社 2021-05-20 — — WO disclosed
EP-3805198-A1 COMPOUND, SALT THEREOF AND LIPID PARTICLES FUJIFILM Corporation (JP) 2021-04-14 — — EP disclosed
US-20210085604-A1 COMPOUND OR SALT THEREOF AND LIPID PARTICLES FUJIFILM CORPORATION (JP) 2021-03-25 — — US disclosed
CN-112262122-A Compound or salt thereof, and lipid particle 富士胶片株式会社 2021-01-22 — — CN disclosed
WO-2020246581-A1 LIPID COMPOSITION 富士フイルム株式会社 2020-12-10 — — WO disclosed
EP-2788316-B1 BRANCHED ALKYL AND CYCLOALKYL TERMINATED BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS ALNYLAM PHARMACEUTICALS INC (US) 2019-04-24 — — EP disclosed
US-9463247-B2 Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents ALNYLAM PHARMACEUTICALS, INC. (US) 2016-10-11 — — US disclosed
US-20150005363-A1 Branched Alkyl And Cycloalkyl Terminated Biodegradable Lipids For The Delivery Of Active Agents BANK OF AMERICA, N.A. 2015-01-01 — — US disclosed
WO-2013086322-A1 BRANCHED ALKYL AND CYCLOALKYL TERMINATED BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS ALNYLAM PHARMACEUTICALS, INC. (US) 2013-06-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150005363-A1 Branched Alkyl And Cycloalkyl Terminated Biodegradable Lipids For The Delivery Of Active Agents LIPA, CETP, APOB KMT2A 4372/4885CYP1A2 2924/4885TDP1 1275/4885
US-12370143-B2 Compound or salt thereof and lipid particles NR1H3, NR1H2, LDLR KMT2A 1797/4885CYP1A2 1806/4885TDP1 3943/4885
US-12285525-B2 Compound or salt thereof and lipid particles NR1H3, NR1H2, LDLR KMT2A 1797/4885CYP1A2 1806/4885TDP1 3943/4885
US-20260102348-A1 COMPOUND OR SALT THEREOF AND LIPID PARTICLES LDLR, NR1H3, NR1H2 KMT2A 2382/4885CYP1A2 3645/4885TDP1 3096/4885
US-20210085604-A1 COMPOUND OR SALT THEREOF AND LIPID PARTICLES NR1H3, NR1H2, LDLR KMT2A 1812/4885CYP1A2 1867/4885TDP1 3999/4885
US-20250114305-A1 LIPIDIC COMPOUNDS, AND USES THEREOF NR1H2, NR1H3, LPAR3 KMT2A 3189/4885CYP1A2 320/4885TDP1 4781/4885
US-12508226-B2 Lipid composition APOB, NAF1, SLC27A1 KMT2A 2210/4885CYP1A2 4015/4885TDP1 2967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.